KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 97 | −7 |
| Shares | 23.4M | 2.46K | 23.8M | +405.6K (+1.7%) |
| Value | $408.2M | $43.0K | $314.6M | −$93.6M (−22.9%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 1,500,000 | $19.8M | 1.47% |
| Great Point Partners LLC | 411,937 | $5.45M | 1.22% |
| Sphera Funds Management Ltd. | 316,200 | $4.18M | 0.50% |
| Mangrove Partners | 92,000 | $1.22M | 0.09% |
| Alps Advisors Inc | 28,274 | $374.0K | 0.00% |
| Evoke Wealth, LLC | 25,583 | $338.0K | 0.01% |
| Prudential Financial Inc | 19,035 | $252.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 16,982 | $225.0K | 0.00% |
| Corton Capital Inc. | 15,991 | $212.0K | 0.09% |
| Price T Rowe Associates Inc | 14,661 | $194.0K | 0.00% |
| Gsa Capital Partners LLP | 11,499 | $152.0K | 0.02% |
| Aquatic Capital Management LLC | 2,500 | $33.0K | 0.06% |
| Quantbot Technologies LP | 2,200 | $29.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 1,643 | $21.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,005 | $13.0K | 0.00% |
| Washington Trust Advisors, Inc. | 68 | $1.00K | 0.00% |
Sold out (23)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Janus Henderson Group PLC | 1,141,683 | $19.9M |
| Emerald Advisers, LLC | 304,113 | $5.31M |
| Nicholas Investment Partners, LP | 217,389 | $3.79M |
| Stonepine Capital Management, LLC | 200,000 | $3.49M |
| Emerald Mutual Fund Advisers Trust | 136,554 | $2.38M |
| Millennium Management LLC | 36,715 | $641.0K |
| Massachusetts Financial Services Co | 31,254 | $545.0K |
| HRT Financial LP | 27,296 | $476.0K |
| Susquehanna Fundamental Investments, LLC | 23,871 | $417.0K |
| Jane Street Group, LLC | 19,797 | $345.0K |
| ExodusPoint Capital Management, LP | 19,173 | $335.0K |
| Los Angeles Capital Management LLC | 18,229 | $318.0K |
| Tibra Equities Europe Ltd | 14,300 | $250.0K |
| Boothbay Fund Management, LLC | 14,036 | $245.0K |
| Invesco Ltd. | 10,222 | $178.0K |
| Pinz Capital Management, LP | 6,000 | $105.0K |
| Simplex Trading, LLC | 3,623 | $88.0K |
| Group One Trading, L.P. | 2,689 | $47.0K |
| Lindbrook Capital, LLC | 1,000 | $17.0K |
| Penserra Capital Management LLC | 560 | $9.00K |
| Cutler Group LP | 100 | $1.00K |
| Harbour Investments, Inc. | 1 | $0 |
| Parallel Advisors, LLC | 8 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| First Mercantile Trust Co | 2,457 | $43.0K |